INSIGHTS ON CLINICAL TRIAL DESIGN
-
Human Abuse Potential: Subjective Ratings
Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.
-
Accelerate Your Oncology Breakthroughs
Finding the right partnership can help your oncology clinical trials overcome trial complexities through strategic planning, a deep scientific understanding, and operational excellence.
-
A New Blueprint For Transforming Feasibility And Recruitment
Discover how a connected approach links feasibility and recruitment, using real-world data to design realistic protocols, reach the right patients, and accelerate enrollment with confidence.
-
Challenges, Opportunities For Recruitment In The Digital Age
Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.
-
Vendor Selection Bias: Why Structured Decisions Often Fail12/22/2025
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
How The Right Meetings Make Patient-Centered Trial Design Possible7/30/2025
Including patients in trial design improves recruitment, retention, and site experience. Explore practical ways sponsors can gather early input—without disrupting timelines or adding complexity.
-
The Final DCT Guidance: I'm Not Mad At It12/13/2024
Explore the FDA's 2024 final guidance on DCTs, including key updates that address previous concerns, affecting healthcare providers, sub-investigators, and sponsors.
-
Rethinking Alzheimer's Trial Recruitment And Why It Can't Wait1/14/2026
Alzheimer's trials face urgent recruitment challenges. Data-driven strategies, digital tools, and community engagement can accelerate enrollment and improve retention in this complex therapeutic space.
-
The Next Frontier In Early Phase Oncology Trials10/18/2024
This session explores the pivotal role of First-in-Human and early phase oncology trials in drug development, emphasizing the importance of comprehensive planning for successful execution.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.
-
Explore an innovative, automated approach that streamlines processes, strengthens financial controls, and accelerates readiness for Equity Events/Sox Controls, and much more.
-
With over 15 years of RTSM experience, high-touch quality management, and forward-thinking technology, our solutions enhance trial speed, accuracy, and operational efficiency.
-
Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.
-
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.